Sign in
4

Changes in Ownership

CAPRICOR THERAPEUTICS, INC. Filed Acc 0001593087-26-000005

CHIEF FINANCIAL OFFICER sold 25,000 shares at $30.13 ($753,153)

  • CHIEF FINANCIAL OFFICER acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-03-31 Option exercise 10b5-1 +25,000 $3.18 $79,500 33,223 D: show line 1 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-03-31 Sale 10b5-1 −25,000 $30.13 $753,153 8,223 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $30.13 · $753,153

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-03-31 Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 141,980 D: show line 3 in the form
Loading xslF345X06/form4-04012026_080406.xml…